药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Trilostane
Azimilide
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Azimilide.
Trilostane
Fluspirilene
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Fluspirilene.
Trilostane
Prenylamine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Prenylamine.
Trilostane
Terlipressin
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Terlipressin.
Trilostane
Aceprometazine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Aceprometazine.
Trilostane
Probucol
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Probucol.
Trilostane
Gemifloxacin
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Gemifloxacin.
Trilostane
Papaverine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Papaverine.
Trilostane
Epitizide
Indacaterol may increase the hypokalemic activities of Epitizide.
Trilostane
Cyclopenthiazide
Indacaterol may increase the hypokalemic activities of Cyclopenthiazide.
Trilostane
Quinethazone
Indacaterol may increase the hypokalemic activities of Quinethazone.
Trilostane
Tertatolol
Tertatolol may decrease the bronchodilatory activities of Indacaterol.
Trilostane
Mepindolol
Mepindolol may decrease the bronchodilatory activities of Indacaterol.
Trilostane
Cloranolol
Cloranolol may decrease the bronchodilatory activities of Indacaterol.
Trilostane
Bupranolol
Bupranolol may decrease the bronchodilatory activities of Indacaterol.
Trilostane
Bopindolol
Bopindolol may decrease the bronchodilatory activities of Indacaterol.
Trilostane
Penbutolol
Penbutolol may decrease the bronchodilatory activities of Indacaterol.
Trilostane
Tianeptine
The risk or severity of hypertension can be increased when Indacaterol is combined with Tianeptine.
Trilostane
Imipramine oxide
The risk or severity of hypertension can be increased when Imipramine oxide is combined with Indacaterol.
Trilostane
Iprindole
The risk or severity of hypertension can be increased when Iprindole is combined with Indacaterol.